Docetaxel, Oxaliplatin, and 5‐Fluorouracil (DOF) in Metastatic and Unresectable Gastric/Gastroesophageal Junction Adenocarcinoma: A Phase II Study with Long‐Term Follow‐Up

LESSONS LEARNED. Adding docetaxel to the modified FOLFOX7 backbone (DOF) is a feasible three‐drug combination therapy for advanced gastric cancer with high activity, providing evidence that leucovorin is not necessary in this setting. The DOF regimen represents an alternative to the FLOT (5‐FU 2,600...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Oncologist
Main Authors: Rosenberg, Ari Joseph, Rademaker, Alfred, Hochster, Howard S., Ryan, Theresa, Hensing, Thomas, Shankaran, Veena, Baddi, Lisa, Mahalingam, Devalingam, Mulcahy, Mary F., Benson, Al B.
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley & Sons, Inc. 2019
Assuntos:
Clinical Trial Results
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6693711/
https://ncbi.nlm.nih.gov/pubmed/31138725
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2019-0330
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados